Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.9735 +0.1645 (+20.33%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....

Via Benzinga

Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options

December 21, 2021

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...

Via FinancialNewsMedia

5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again ↗

December 20, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NY...

Via Benzinga

The 10 Most Shorted Stocks Right Now for Friday, Dec. 17 ↗

December 17, 2021

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!

Via InvestorPlace

Longeveron Inc. (NASDAQ:LGVN) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗

December 17, 2021

San Diego, CA -- (SBWIRE) -- 12/17/2021 -- An investigation on behalf of current long-term investors in shares of Longeveron Inc. (NASDAQ:LGVN) concerning potential breaches of fiduciary duties by...

Via SBWire

5 Short Squeeze Candidates To Watch: Petros Pharma Tops List With 254% Cost To Borrow, One Of Highest Figures On Record ↗

December 13, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC...

Via Benzinga

3 Predictions for the Stock Market in 2022 ↗

December 10, 2021

Precisely predicting what the market will do is an easy way to get everything wrong, but here are three trends to look for in 2022.

Via InvestorPlace

Why Longeveron’s Good News Isn’t Telling Us the Whole Truth ↗

December 10, 2021

LGVN stock has soared in 2021 with the latest upbeat FDA news but a closer look at Longeveron's financials tells a different story.

Via InvestorPlace

Topics Initial Public Offering

18 Stocks Moving in Friday's Pre-Market Session ↗

December 10, 2021

Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; US Initial Jobless Claims Drop To 52-Year Low ↗

December 09, 2021

Following the market opening Thursday, the Dow traded down 0.22% to 35,676.45 while the NASDAQ fell 0.30% to 15,740.38. The S&P also fell, dropping 0.21% to 4,691.18. The U.S...

Via Benzinga

Topics Stocks

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts ↗

December 07, 2021

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

Via InvestorPlace

Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027

December 08, 2021

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...

Via FinancialNewsMedia

2 Big Stock Bets That Are Insiders Are Buying Now ↗

December 06, 2021

Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.

Via InvestorPlace

Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS) ↗

December 06, 2021

HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year Orphan Drug Designation confers certain benefits and may result in...

Via Benzinga

58 Biggest Movers From Friday ↗

December 06, 2021

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...

Via Benzinga

Is Longeveron a Good Biotech Stock to Buy? ↗

December 05, 2021

Stem cell therapies are back in vogue, at least for this Miami-based biotechnology company.

Via The Motley Fool

Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb ↗

December 03, 2021

Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings ↗

December 03, 2021

Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37. The U.S. has the...

Via Benzinga

Topics Stocks

41 Stocks Moving In Friday's Mid-Day Session ↗

December 03, 2021

Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to...

Via Benzinga

Topics Initial Public Offering

Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast ↗

December 03, 2021

Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65. The...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 03, 2021

Good morning, investor! We're at the end of the week and it starts off with the biggest pre-market stock movers for Friday!

Via InvestorPlace

Longeveron Shares Gain After Lead Product Gets FDA Orphan Drug Tag For Type Of Congenital Heart Defect ↗

December 03, 2021

The FDA has granted Orphan Drug designation to Longeveron Inc's (NASDAQ: LGVN) lead investigational product Lomecel-B for Hypoplastic left heart syndrome (...

Via Benzinga

20 Stocks Moving in Friday's Pre-Market Session ↗

December 03, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) rose 27.2% to $0.52 in pre-market trading. Biolase reporte in Form4 filing that President bought 70,000 shares at an average price of $0.45...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 01, 2021

Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

23 Stocks Moving in Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a...

Via Benzinga

Longeveron Shares Fall After Raising $20M Capital Via Equity ↗

December 01, 2021

Longeveron Inc (NASDAQ: LGVN) has announced a private placement of approximately $20.5 million of its common stock and warrants. The purchase price for one share...

Via Benzinga

Longeveron Announces Clinical Collaboration To Study Cell Therapy Aging Treatment In Japan: Why It Matters ↗

November 30, 2021

Longeveron Inc. (NASDAQ: LGVN) announced Friday a clinical trial collaboration to study its lead investigational asset, Lomecel-B. What Happened: Florida-based Longeverson said...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.